Stifel Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)
Stifel analyst James Condulis reiterated a Buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

